To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CRELD2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
277 supporting clones for gene CRELD2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI462292 testis .a 1 to 149 1 to 149   tiling clone,   149/149
(100 %)
3 diff
(98.0 %id)
AL541525 placenta .a 20 to 838 1 to 818   fully sequenced,   818/818
(100 %)
10 diff
(98.8 %id)
DQ470679   .a 25 to 1599 1 to 1575 exact tiling clone,   1575/1575
(100 %)
0 diff
(100 %id)
NM_001135101.1   .a 25 to 1599 1 to 1575 exact RefSeq,   1575/1575
(100 %)
0 diff
(100 %id)
BG724268 testis .a 33 to 149 1 to 117       117/117
(100 %)
4 diff
(96.6 %id)
DA135020 alzheimer cortex .a 42 to 595 2 to 557   capped   556/556
(100 %)
5 diff
(99.2 %id)
DB495768 hypothalamus .a 45 to 546 1 to 502       502/502
(100 %)
3 diff
(99.5 %id)
DB495834 hypothalamus .a 45 to 548 1 to 504       504/507
(99 %)
4 diff
(99.3 %id)
DB105558 thymus .a 45 to 588 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
AW732270 Kidney, renal cell adenocarcinoma .a 47 to 660 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BG165521 hypernephroma, cell line, Kidney .a 49 to 757 5 to 707       703/1114
(63 %)
22 diff
(98.1 %id)
BI908164 leukocyte .a 49 to 851 1 to 807       807/808
(99 %)
9 diff
(98.9 %id)
TI_57235537   .a 49 to 851 57 to 863       807/864
(93 %)
15 diff
(98.3 %id)
CA495376   .a 52 to 633 1 to 588       588/951
(61 %)
18 diff
(98.2 %id)
BF307702 muscle, rhabdomyosarcoma .a 54 to 459 1 to 406       406/406
(100 %)
0 diff
(100 %id)
BF309193 muscle, rhabdomyosarcoma .a 54 to 459 1 to 403       403/403
(100 %)
3 diff
(99.3 %id)
BG684431 B-cells, primary B-cells from tonsils (cell line) .a 54 to 459 1 to 406       406/406
(100 %)
0 diff
(100 %id)
BG758351 B-cells, primary B-cells from tonsils (cell line) .a 54 to 459 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
BU855968 ovary, teratocarcinoma, cell line .a 59 to 644 27 to 620       594/1065
(55 %)
19 diff
(98.3 %id)
BQ892386 sympathetic trunk .a 60 to 687 1 to 635       635/958
(66 %)
15 diff
(98.5 %id)
BU845451 ovary, teratocarcinoma, cell line .a 61 to 720 1 to 665       665/1018
(65 %)
28 diff
(97.3 %id)
BU850273 ovary, teratocarcinoma, cell line .a 61 to 752 1 to 702       702/965
(72 %)
37 diff
(96.2 %id)
BE019348 muscle, rhabdomyosarcoma .a 63 to 684 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BX337280 Placenta Cot 25-normalized .a 65 to 929 1 to 864   fully sequenced,   864/864
(100 %)
7 diff
(99.2 %id)
BG771807 testis .a 66 to 149 1 to 84       84/84
(100 %)
4 diff
(95.3 %id)
CB053137 leiomyosarcoma, soft tissue .a 68 to 544 10 to 487       478/487
(98 %)
9 diff
(98.2 %id)
DB450949 testis .a 70 to 550 1 to 481       481/481
(100 %)
2 diff
(99.6 %id)
DT217815 brain .a 71 to 697 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BE250599 muscle, rhabdomyosarcoma .a 74 to 439 1 to 367       367/367
(100 %)
1 diff
(99.8 %id)
BE297368 muscle, rhabdomyosarcoma .a 74 to 439 1 to 366       366/366
(100 %)
0 diff
(100 %id)
DB048895 testis .a 77 to 636 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BF304983 muscle, rhabdomyosarcoma .a 80 to 459 1 to 377       377/377
(100 %)
3 diff
(99.3 %id)
BF309869 muscle, rhabdomyosarcoma .a 80 to 459 1 to 378       378/378
(100 %)
2 diff
(99.5 %id)
BM047889 carcinoma, cell line, Prostate .a 80 to 459 1 to 379       379/379
(100 %)
6 diff
(98.5 %id)
BU168729 melanotic melanoma, cell line, skin .a 80 to 574 24 to 519       496/1160
(42 %)
13 diff
(98.9 %id)
BQ678099 melanotic melanoma, cell line, skin .a 82 to 573 1 to 492       492/939
(52 %)
7 diff
(99.3 %id)
BQ959139 carcinoma, cell line, Prostate .a 82 to 690 1 to 621       621/1062
(58 %)
45 diff
(95.8 %id)
CD359405 testis .a 84 to 726 1 to 653       653/934
(69 %)
26 diff
(97.3 %id)
BG490334 large cell carcinoma, lung .a 85 to 459 1 to 375       375/375
(100 %)
2 diff
(99.5 %id)
BU156926 epithelioid carcinoma, Pancreas .a 85 to 664 10 to 594       585/987
(59 %)
27 diff
(97.3 %id)
BM451736 eye, retinoblastoma .a 86 to 744 1 to 661       661/1045
(63 %)
11 diff
(99.0 %id)
AW629706 2 pooled high-grade transitional celltumors, genitourinary tract .a 89 to 675 1 to 587       587/587
(100 %)
0 diff
(100 %id)
AW629707 2 pooled high-grade transitional celltumors, genitourinary tract .a 89 to 683 1 to 595       595/596
(99 %)
3 diff
(99.5 %id)
BF313744 brain, neuroblastoma .a 90 to 459 1 to 370       370/370
(100 %)
1 diff
(99.8 %id)
BG386391 adenocarcinoma cell line, colon .a 90 to 459 1 to 372       372/372
(100 %)
5 diff
(98.7 %id)
BI198593 brain, neuroblastoma .a 90 to 459 1 to 370       370/370
(100 %)
3 diff
(99.2 %id)
BU542977 carcinoma, cell line, Prostate .a 93 to 683 1 to 600       600/1083
(55 %)
20 diff
(98.2 %id)
DB461405 testis .a 99 to 593 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
BE741211 adenocarcinoma cell line, ovary .a 104 to 439 1 to 335       335/335
(100 %)
1 diff
(99.8 %id)
BE260377 brain, neuroblastoma .a 105 to 440 1 to 336       336/336
(100 %)
2 diff
(99.5 %id)
BE382658 brain, neuroblastoma .a 105 to 439 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BE261201 brain, neuroblastoma .a 106 to 439 1 to 334       334/334
(100 %)
0 diff
(100 %id)
BE261301 brain, neuroblastoma .a 106 to 439 1 to 334       334/334
(100 %)
2 diff
(99.5 %id)
CN256958 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 110 to 494 1 to 385       385/385
(100 %)
0 diff
(100 %id)
CN256961 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 111 to 406 1 to 296       296/296
(100 %)
0 diff
(100 %id)
BE744257 adenocarcinoma cell line, ovary .a 115 to 439 14 to 335       322/335
(96 %)
6 diff
(98.3 %id)
DN995787 breast cancer, Mammary gland (cancer tissue) .a 116 to 685 9 to 578       570/578
(98 %)
7 diff
(98.8 %id)
BG766289 melanotic melanoma, high MDR (cell line), skin .a 119 to 459 1 to 340       340/340
(100 %)
5 diff
(98.6 %id)
BM047908 carcinoma, cell line, Prostate .a 119 to 459 1 to 342       342/342
(100 %)
5 diff
(98.6 %id)
BE796766 lung, small cell carcinoma .a 142 to 439 1 to 298       298/298
(100 %)
0 diff
(100 %id)
TI_1948105650   .a 159 to 749 140 to 736       597/1160
(51 %)
20 diff
(98.3 %id)
BF203225 muscle, rhabdomyosarcoma .a 180 to 459 144 to 435       414/435
(95 %)
29 diff
(93.4 %id)
AA306943   .a 298 to 718 1 to 419       419/422
(99 %)
3 diff
(99.3 %id)
AW844454 colon_normal .a 368 to 744 8 to 384       377/385
(97 %)
11 diff
(97.2 %id)
F11182 brain, total brain .a 386 to 672 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
N28564 melanocyte .a 420 to 733 1 to 314       314/314
(100 %)
0 diff
(100 %id)
AL568947 placenta .a 808 to 1452 766 to 123   fully sequenced,   644/766
(84 %)
9 diff
(98.9 %id)
BX337279 Placenta Cot 25-normalized .a 868 to 1554 688 to 1   fully sequenced,   688/688
(100 %)
7 diff
(99.0 %id)
TI_149291196   .a 939 to 1587 779 to 132   AAA   648/648
(100 %)
39 diff
(94.0 %id)
CA426419 cell lines, Chondrosarcoma .a 951 to 1597 666 to 19   AAA   648/648
(100 %)
1 diff
(99.9 %id)
AI872092 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 952 to 1597 664 to 20   AAA   645/645
(100 %)
11 diff
(98.3 %id)
AI268313 carcinoid, lung .a 961 to 1587 664 to 37   AAA   628/628
(100 %)
26 diff
(95.9 %id)
AW373048 breast .a 965 to 1481 31 to 562       484/563
(85 %)
39 diff
(93.1 %id)
TI_154119442   .a 969 to 1599 709 to 79   AAA   631/993
(63 %)
1 diff
(99.9 %id)
N83852   .a 975 to 1298 1 to 319       319/320
(99 %)
11 diff
(96.6 %id)
AI935261 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 979 to 1597 630 to 12   AAA   619/619
(100 %)
10 diff
(98.4 %id)
BM311061 Pancreas, Purified pancreatic islet .a 983 to 1421 1 to 439       439/439
(100 %)
0 diff
(100 %id)
CB053136 leiomyosarcoma, soft tissue .a 1046 to 1587 578 to 34   AAA   545/545
(100 %)
4 diff
(99.3 %id)
BE250372 muscle, rhabdomyosarcoma .a 1065 to 1524 471 to 10       462/490
(94 %)
6 diff
(98.8 %id)
BE831272 marrow .a 1066 to 1315 264 to 14       249/265
(93 %)
4 diff
(98.5 %id)
H99879 melanocyte .a 1150 to 1593 443 to 1       443/443
(100 %)
7 diff
(98.5 %id)
AI242595 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1164 to 1587 423 to 1       423/427
(99 %)
2 diff
(99.6 %id)
AW371696 breast .a 1173 to 1360 9 to 198       190/211
(90 %)
9 diff
(95.8 %id)
BQ351428 head_neck .a 1174 to 1513 53 to 392       340/392
(86 %)
14 diff
(96.5 %id)
DB508015 testis .a 1181 to 1597 1 to 417     Submitted on the opposite strand 417/417
(100 %)
2 diff
(99.6 %id)
BU931834 ovary, teratocarcinoma, cell line .a 1181 to 1597 1 to 417   AAA   417/417
(100 %)
0 diff
(100 %id)
AI474318 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1189 to 1589 402 to 2       401/402
(99 %)
1 diff
(99.8 %id)
AW406541 lymph .a 1197 to 1587 433 to 43   AAA Submitted on the opposite strand 391/391
(100 %)
0 diff
(100 %id)
AA582660 Kidney, kidney tumor .a 1205 to 1595 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
CV409744 leiomios .a 1232 to 1422 7 to 199       191/199
(95 %)
13 diff
(93.5 %id)
AI368413 brain, glioblastoma (pooled) .a 1233 to 1588 355 to 1       355/355
(100 %)
2 diff
(99.5 %id)
AA643893 breast .a 1251 to 1587 336 to 1       336/336
(100 %)
1 diff
(99.8 %id)
EC442834 Prostate .a 1256 to 1357 1 to 102       102/102
(100 %)
0 diff
(100 %id)
EC545789 Prostate .a 1256 to 1349 1 to 93       93/100
(93 %)
4 diff
(96.0 %id)
CA444947 lung, Metastatic Chondrosarcoma .a 1265 to 1587 341 to 19   AAA   323/331
(97 %)
0 diff
(100 %id)
AA093791   .a 1268 to 1572 1 to 295       295/314
(93 %)
17 diff
(94.6 %id)
F08850 brain, total brain .a 1271 to 1587 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BE926434 breast .a 1275 to 1532 259 to 3       257/265
(96 %)
6 diff
(97.8 %id)
DB509626 testis .a 1279 to 1597 1 to 319     Submitted on the opposite strand 319/319
(100 %)
12 diff
(96.3 %id)
BE672762 carcinoid, lung .a 1282 to 1587 341 to 36   AAA   306/306
(100 %)
1 diff
(99.7 %id)
AI264807 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1301 to 1587 287 to 1       287/287
(100 %)
0 diff
(100 %id)
NM_024324.3   .b 1 to 1428 1 to 1428 exact RefSeq,   1428/1428
(100 %)
0 diff
(100 %id)
AL559540 T cells from T cell leukemia .b 12 to 790 1 to 779   tiling clone, fully sequenced,   779/779
(100 %)
5 diff
(99.4 %id)
BG676430 skin, squamous cell carcinoma .b 26 to 953 1 to 933       933/938
(99 %)
45 diff
(95.3 %id)
CR992667 T-Lymphocytes .b 33 to 735 1 to 703       703/704
(99 %)
4 diff
(99.5 %id)
BG745633 Spleen .b 36 to 435 1 to 400       400/400
(100 %)
1 diff
(99.8 %id)
CA454813   .b 39 to 780 1 to 745       745/883
(84 %)
22 diff
(97.6 %id)
BE786035 large cell carcinoma, lung .b 43 to 802 1 to 781       779/1131
(68 %)
62 diff
(94.6 %id)
AL522355 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 46 to 758 1 to 710   fully sequenced,   710/710
(100 %)
7 diff
(99.1 %id)
BM552953 brain, medulla .b 46 to 829 1 to 786       786/1120
(70 %)
7 diff
(99.4 %id)
BU856944 adenocarcinoma, cell line, breast .b 47 to 776 35 to 767       733/1000
(73 %)
17 diff
(98.3 %id)
BE250199 muscle, rhabdomyosarcoma .b 50 to 415 1 to 366       366/366
(100 %)
0 diff
(100 %id)
BU943969 adenocarcinoma, cell line, breast .b 54 to 829 1 to 784       784/968
(80 %)
20 diff
(98.0 %id)
CN256962 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 59 to 766 1 to 708       708/708
(100 %)
1 diff
(99.9 %id)
BG403139 bladder, transitional cell papilloma, cell line .b 61 to 830 1 to 764       764/771
(99 %)
10 diff
(98.8 %id)
BC050675 Pancreas, epithelioid carcinoma .b 62 to 1416 1 to 1355   available from MGC, AAA   1355/1355
(100 %)
4 diff
(99.8 %id)
DQ470678   .b 62 to 1423 1 to 1362   tiling clone, AAA   1362/1362
(100 %)
1 diff
(100.0 %id)
BF528484 anaplastic oligodendroglioma with 1p/19qloss, brain .b 62 to 832 1 to 774       774/907
(85 %)
11 diff
(98.8 %id)
CA454110   .b 63 to 829 1 to 772       772/868
(88 %)
22 diff
(97.5 %id)
TI_57190931   .b 64 to 765 50 to 751       702/704
(99 %)
6 diff
(99.2 %id)
BI857757 breast, mammary adenocarcinoma, cell line .b 65 to 765 1 to 701       701/703
(99 %)
6 diff
(99.2 %id)
CA487845   .b 66 to 912 1 to 851       851/893
(95 %)
20 diff
(97.8 %id)
BQ225215 melanotic melanoma, skin .b 67 to 894 1 to 834       834/892
(93 %)
29 diff
(96.8 %id)
BQ928924 carcinoma, cell line, Prostate .b 69 to 823 1 to 753       753/911
(82 %)
33 diff
(96.4 %id)
BQ923120 carcinoma, cell line, Prostate .b 69 to 779 1 to 711       711/1169
(60 %)
14 diff
(98.9 %id)
BU845910 ovary, teratocarcinoma, cell line .b 70 to 777 1 to 710   AAA   710/947
(74 %)
19 diff
(98.0 %id)
AK225930 Spleen .b 71 to 1277 1 to 1207       1207/1207
(100 %)
1 diff
(100.0 %id)
AY358355   .b 72 to 1430 1 to 1359   tiling clone,   1359/1364
(99 %)
2 diff
(99.9 %id)
CN256963 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 93 to 838 1 to 746       746/746
(100 %)
1 diff
(99.9 %id)
BU185810 ductal carcinoma, cell line, Pancreas .b 95 to 830 1 to 744   AAA   744/992
(75 %)
25 diff
(97.5 %id)
CA495369   .b 109 to 907 1 to 800       800/891
(89 %)
10 diff
(98.9 %id)
CV026457 mixed .b 136 to 753 1 to 618       618/618
(100 %)
0 diff
(100 %id)
EL734666 mixed .b 136 to 788 1 to 650       650/654
(99 %)
5 diff
(99.3 %id)
BU163124 ductal carcinoma, cell line, Pancreas .b 171 to 1055 9 to 902       892/903
(98 %)
23 diff
(97.5 %id)
BU162890 ductal carcinoma, cell line, Pancreas .b 172 to 1099 1 to 936   AAA   936/1049
(89 %)
48 diff
(95.5 %id)
BQ689307 ductal carcinoma, cell line, Pancreas .b 172 to 1000 1 to 830       830/947
(87 %)
6 diff
(99.4 %id)
BU180242 ductal carcinoma, cell line, Pancreas .b 251 to 998 1 to 751       751/924
(81 %)
8 diff
(99.2 %id)
AW955280   .b 275 to 988 1 to 714       714/714
(100 %)
2 diff
(99.8 %id)
AA186619 Pancreas .b 365 to 821 1 to 475       475/502
(94 %)
22 diff
(95.7 %id)
BI602376 brain, hypothalamus .b 441 to 1069 4 to 630       627/630
(99 %)
9 diff
(98.6 %id)
TI_45215693   .b 441 to 1069 94 to 720       627/720
(87 %)
9 diff
(98.8 %id)
DB488660 hypothalamus .b 445 to 917 1 to 473       473/473
(100 %)
3 diff
(99.4 %id)
BQ925035 large cell carcinoma, lung .b 462 to 1136 1 to 681       681/981
(69 %)
26 diff
(97.4 %id)
BE740673 adenocarcinoma cell line, ovary .b 467 to 1335 1 to 863       859/915
(93 %)
41 diff
(95.6 %id)
BG745758 Spleen .b 468 to 1376 949 to 40       910/950
(95 %)
13 diff
(98.7 %id)
ES310096 scalp interfollicular dermis, skin .b 500 to 978 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
BG489873 large cell carcinoma, lung .b 506 to 1305 1 to 813       813/813
(100 %)
19 diff
(97.7 %id)
BG766118 melanotic melanoma, high MDR (cell line), skin .b 507 to 1429 1 to 928   AAA   928/928
(100 %)
24 diff
(97.5 %id)
BG768676 melanotic melanoma, high MDR (cell line), skin .b 507 to 1237 1 to 733       733/733
(100 %)
4 diff
(99.5 %id)
BU956577 adenocarcinoma, cell line, breast .b 518 to 1331 1 to 819       819/892
(91 %)
11 diff
(98.8 %id)
BU957520 adenocarcinoma, cell line, breast .b 518 to 1379 1 to 874       874/918
(95 %)
24 diff
(97.4 %id)
BU957640 adenocarcinoma, cell line, breast .b 518 to 1254 1 to 740       740/943
(78 %)
11 diff
(98.9 %id)
TI_154193108   .b 535 to 1141 50 to 644       536/894
(59 %)
25 diff
(97.3 %id)
CF127573 Chondrosarcoma Lung Metastasis cell lines, lung .b 536 to 945 1 to 399       340/399
(85 %)
13 diff
(96.8 %id)
BU072575 Pancreas, Purified pancreatic islet .b 583 to 955 1 to 373   fully sequenced,   373/373
(100 %)
0 diff
(100 %id)
BU179567 melanotic melanoma, cell line, skin .b 590 to 1420 1 to 832   AAA   832/832
(100 %)
7 diff
(99.2 %id)
H52011 brain .b 600 to 817 1 to 222       222/222
(100 %)
4 diff
(98.2 %id)
BQ687800 ductal carcinoma, cell line, Pancreas .b 621 to 1426 1 to 804   AAA   804/804
(100 %)
7 diff
(99.2 %id)
BU625731 cell lines, Enchondroma .b 666 to 1422 775 to 19   AAA   757/757
(100 %)
0 diff
(100 %id)
BE250620 muscle, rhabdomyosarcoma .b 668 to 1356 694 to 5       772/918
(84 %)
23 diff
(97.5 %id)
BU621170 cell lines, Chondrosarcoma .b 673 to 1416 762 to 19   AAA   744/744
(100 %)
0 diff
(100 %id)
BU621400 cell lines, Chondrosarcoma .b 674 to 1416 760 to 19   AAA   742/742
(100 %)
1 diff
(99.9 %id)
AL562085 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 697 to 1401 703 to 1   fully sequenced,   703/703
(100 %)
28 diff
(96.1 %id)
BG750264 eye, normal pigmented retinal epithelium .b 705 to 1430 1 to 726       726/771
(94 %)
8 diff
(99.0 %id)
AL581138 T cells from T cell leukemia .b 760 to 1365 618 to 13   fully sequenced,   606/618
(98 %)
4 diff
(99.4 %id)
CN256959 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 817 to 1427 1 to 611       611/612
(99 %)
6 diff
(99.1 %id)
AW605414 denis_drash .b 823 to 1254 29 to 462       434/493
(88 %)
26 diff
(94.8 %id)
BE736986 adenocarcinoma, Pancreas .b 824 to 1416 25 to 619       595/619
(96 %)
9 diff
(98.6 %id)
AA242749 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 868 to 1416 548 to 1       548/548
(100 %)
6 diff
(99.0 %id)
BQ774567 Chondrosarcoma Grade II, Left Pelvis .b 875 to 1426 570 to 19   AAA   552/552
(100 %)
0 diff
(100 %id)
AI673056 thymus, pooled .b 880 to 1416 547 to 11   AAA   537/537
(100 %)
0 diff
(100 %id)
BQ772339 Chondrosarcoma Grade II, Left Pelvis .b 881 to 1416 554 to 19   AAA   536/536
(100 %)
0 diff
(100 %id)
AI419938 pooled .b 886 to 1416 548 to 18   AAA   529/531
(99 %)
6 diff
(98.9 %id)
AW051818 brain, glioblastoma (pooled) .b 888 to 1417 529 to 1       529/529
(100 %)
1 diff
(99.9 %id)
BF128703 B-cells, primary B-cells from tonsils (cell line) .b 889 to 1414 1 to 531       531/710
(74 %)
8 diff
(98.9 %id)
AW772559 normal epithelium, thyroid .b 892 to 1217 4 to 327     Submitted on the opposite strand 324/327
(99 %)
14 diff
(95.8 %id)
AI636626 Kidney, renal cell tumor .b 895 to 1423 553 to 23   AAA   531/539
(98 %)
15 diff
(97.3 %id)
BE714202 head_neck .b 900 to 1342 6 to 445       440/445
(98 %)
6 diff
(98.7 %id)
BE714240 head_neck .b 900 to 1342 20 to 464       445/464
(95 %)
7 diff
(98.5 %id)
AW381506 head_neck .b 901 to 1228 327 to 2       326/327
(99 %)
1 diff
(99.7 %id)
BM311651 Pancreas, Purified pancreatic islet .b 901 to 1430 535 to 6       530/535
(99 %)
0 diff
(100 %id)
BE906649 epithelioid carcinoma, Pancreas .b 901 to 1418 1 to 518       518/522
(99 %)
3 diff
(99.5 %id)
AW591991 pooled .b 904 to 1418 516 to 2       515/516
(99 %)
2 diff
(99.7 %id)
AW592642 pooled .b 904 to 1418 519 to 5       515/519
(99 %)
1 diff
(99.9 %id)
AA614146 adrenal adenoma, adrenal gland .b 906 to 1428 524 to 4       521/526
(99 %)
5 diff
(99.1 %id)
AI829149 adenocarcinoma, Pancreas .b 910 to 1426 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
AA983894 pooled .b 916 to 1418 499 to 2       498/499
(99 %)
12 diff
(97.6 %id)
BU072299 Pancreas, Purified pancreatic islet .b 925 to 1417 493 to 1   fully sequenced,   493/493
(100 %)
1 diff
(99.8 %id)
TI_154144185   .b 927 to 1416 608 to 117   AAA Submitted on the opposite strand 492/872
(56 %)
10 diff
(98.9 %id)
AI005246   .b 931 to 1416 498 to 13   AAA   486/486
(100 %)
5 diff
(99.0 %id)
DW421778 Liver .b 932 to 1217 11 to 296       286/296
(96 %)
8 diff
(97.3 %id)
AI066551 pooled .b 937 to 1418 485 to 4       482/485
(99 %)
1 diff
(99.8 %id)
AI272674 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 939 to 1418 484 to 3       482/484
(99 %)
11 diff
(97.8 %id)
AI148387 heart .b 943 to 1424 482 to 1       482/482
(100 %)
3 diff
(99.4 %id)
BQ003113 Chondrosarcoma, Left Pelvis .b 948 to 1428 498 to 17   AAA   482/482
(100 %)
2 diff
(99.6 %id)
AI189569 placenta .b 949 to 1416 489 to 21   AAA   469/469
(100 %)
10 diff
(97.9 %id)
TI_157604035   .b 949 to 1416 589 to 123   AAA   467/724
(64 %)
9 diff
(98.8 %id)
BQ010874 placenta .b 949 to 1416 486 to 19   AAA   468/475
(98 %)
1 diff
(99.8 %id)
BQ011091 placenta .b 949 to 1416 486 to 19   AAA   468/483
(96 %)
1 diff
(99.8 %id)
AI269298 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 955 to 1416 483 to 23   AAA   461/461
(100 %)
9 diff
(98.1 %id)
AA922166 pooled .b 958 to 1418 462 to 2       461/462
(99 %)
8 diff
(98.3 %id)
AW303516 pooled .b 958 to 1418 462 to 2       461/462
(99 %)
0 diff
(100 %id)
DB566820 hypothalamus .b 964 to 1428 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
DB566887 hypothalamus .b 966 to 1428 1 to 463     Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
DB526810 testis .b 969 to 1426 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AI370747 uterus .b 970 to 1416 447 to 1       447/447
(100 %)
6 diff
(98.7 %id)
AI635507 pooled germ cell tumors .b 970 to 1427 459 to 2       458/461
(99 %)
3 diff
(99.4 %id)
AW027831 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 970 to 1423 473 to 20   AAA   454/454
(100 %)
11 diff
(97.6 %id)
AI148390 heart .b 973 to 1418 451 to 6       446/451
(98 %)
0 diff
(100 %id)
AW371665 breast .b 974 to 1189 217 to 3       215/229
(93 %)
2 diff
(99.2 %id)
DB562168 hypothalamus .b 976 to 1415 1 to 439     Submitted on the opposite strand 437/440
(99 %)
17 diff
(96.2 %id)
DB558006 hypothalamus .b 990 to 1426 1 to 437     Submitted on the opposite strand 437/437
(100 %)
1 diff
(99.8 %id)
AA195084 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 991 to 1403 1 to 411   fully sequenced,   411/411
(100 %)
4 diff
(99.1 %id)
BE464778 carcinoid, lung .b 994 to 1416 425 to 1       425/425
(100 %)
3 diff
(99.3 %id)
AI954835 pooled germ cell tumors .b 997 to 1427 432 to 2       431/432
(99 %)
0 diff
(100 %id)
AA157973 Pancreas .b 1006 to 1418 421 to 7       415/421
(98 %)
9 diff
(97.9 %id)
AI318617 early stage papillary serous carcinoma, ovary .b 1138 to 1427 11 to 301   AAA Submitted on the opposite strand 291/301
(96 %)
6 diff
(98.1 %id)
AI307544 bone marrow, stem cell 34+/38+ .b 1142 to 1421 1 to 281     Submitted on the opposite strand 281/323
(86 %)
4 diff
(98.8 %id)
BG959201 colon .b 1144 to 1413 1 to 268       268/270
(99 %)
18 diff
(93.4 %id)
AA582370 Kidney, kidney tumor .b 1144 to 1424 281 to 1       281/285
(98 %)
0 diff
(100 %id)
R95152 liver and spleen .b 1154 to 1417 267 to 1     Submitted on the opposite strand 267/280
(95 %)
8 diff
(97.2 %id)
EC522421 Prostate .b 1156 to 1270 1 to 113       113/113
(100 %)
2 diff
(98.3 %id)
AW883177 ovary .b 1158 to 1332 176 to 7       170/176
(96 %)
0 diff
(100 %id)
BG958175 colon .b 1162 to 1415 1 to 253       253/253
(100 %)
5 diff
(98.1 %id)
BF509192   .b 1183 to 1416 251 to 18   AAA   234/455
(51 %)
0 diff
(100 %id)
AI674609 Prostate .b 1189 to 1416 246 to 19   AAA   228/228
(100 %)
2 diff
(99.2 %id)
BF437281 Prostate .b 1189 to 1416 246 to 19   AAA   228/228
(100 %)
0 diff
(100 %id)
AI915375 pooled .b 1194 to 1418 228 to 2       227/228
(99 %)
0 diff
(100 %id)
AA905701 pooled .b 1208 to 1418 214 to 4       211/214
(98 %)
0 diff
(100 %id)
AW118291 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1218 to 1420 203 to 1       203/203
(100 %)
0 diff
(100 %id)
FN073084 breast carcinoma .b 1219 to 1283 1 to 64       64/64
(100 %)
1 diff
(98.5 %id)
AA195267 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1241 to 1419 179 to 1   fully sequenced,   179/179
(100 %)
1 diff
(99.5 %id)
FN096743 breast carcinoma .b 1246 to 1335 91 to 1     Submitted on the opposite strand 91/92
(98 %)
1 diff
(99.0 %id)
BG152868 Prostate .b 1272 to 1418 150 to 4       147/150
(98 %)
0 diff
(100 %id)
AW452496   .b 1283 to 1427 162 to 18   AAA   145/146
(99 %)
4 diff
(97.3 %id)
T23908   .b 1285 to 1430 147 to 2     Submitted on the opposite strand 146/149
(97 %)
0 diff
(100 %id)
AI699638 pooled germ cell tumors .b 1286 to 1416 148 to 18   AAA   131/131
(100 %)
1 diff
(99.3 %id)
AA310217   .b 1300 to 1426 1 to 127       127/127
(100 %)
0 diff
(100 %id)
DQ470680   .c 1 to 1994 7 to 2000 exact tiling clone,   1994/2000
(99 %)
6 diff
(99.7 %id)
CD671563 eye, Iris .d 1 to 627 1 to 627   tiling clone,   627/627
(100 %)
0 diff
(100 %id)
CN274645 embryonic stem cells, DMSO-treated H9 cellline .d 5 to 340 1 to 336       336/336
(100 %)
4 diff
(98.9 %id)
BQ936586 carcinoma, cell line, Prostate .d 52 to 939 1 to 891   tiling clone,   891/938
(94 %)
29 diff
(97.0 %id)
CD676293 eye, lens .d 249 to 585 1 to 337       337/337
(100 %)
6 diff
(98.3 %id)
BM049600 carcinoma, cell line, Prostate .d 445 to 575 1 to 132       132/132
(100 %)
4 diff
(97.0 %id)
BI194584 epithelioid carcinoma cell line, Pancreas .d 509 to 575 1 to 68       68/68
(100 %)
3 diff
(95.6 %id)
CD671562 eye, Iris .d 1203 to 1556 370 to 17   tiling clone, AAA   354/354
(100 %)
0 diff
(100 %id)
BC002894 Lung, small cell carcinoma .e 1 to 1229 7 to 1235 exact tiling clone, available from MGC, AAA   1229/1235
(99 %)
6 diff
(99.6 %id)
DQ470676   .e 1 to 1229 7 to 1235 exact AAA   1229/1235
(99 %)
6 diff
(99.6 %id)
DA058845 cerebellum .f 1 to 522 2 to 523   tiling clone, capped   522/526
(99 %)
2 diff
(99.7 %id)
DQ470677   .f 53 to 1300 7 to 1254 exact tiling clone,   1248/1255
(99 %)
10 diff
(99.3 %id)
DB296823 cerebellum .f 773 to 1298 526 to 1   tiling clone,   526/526
(100 %)
1 diff
(99.9 %id)
AK308692 alzheimer cortex .g 1 to 1539 2 to 1554 E28K G310L F311R R312G C313L ... tiling clone,   1554/1554
(100 %)
12 diff
(99.3 %id)
AJ968414 brain .g 119 to 973 1 to 855   tiling clone,   855/855
(100 %)
0 diff
(100 %id)
BU950694 Pancreas, Purified pancreatic islet .h 1 to 464 1 to 464   tiling clone, fully sequenced,   464/464
(100 %)
0 diff
(100 %id)
BU950390 Pancreas, Purified pancreatic islet .h 422 to 1030 609 to 1   tiling clone, fully sequenced,   609/609
(100 %)
7 diff
(98.9 %id)
BC131522 PCR rescued clones .h 998 to 2453 11 to 1467   tiling clone,   1457/1468
(99 %)
12 diff
(99.2 %id)
BU859284 ovary, teratocarcinoma, cell line .i 1 to 803 1 to 812 C243L C244L L245S S246V G248L ... tiling clone,   812/953
(85 %)
13 diff
(98.7 %id)
AK308535 cerebellum .j 1 to 1625 2 to 1626   tiling clone,   1626/1626
(100 %)
1 diff
(100.0 %id)
AL713788 lymph node .j 1025 to 3644 1 to 2637   available from DKFZ, AAA   2637/2637
(100 %)
22 diff
(99.2 %id)
AI468029 pooled .j 1166 to 1621 464 to 7       458/464
(98 %)
0 diff
(100 %id)
AI089129 pooled .j 1187 to 1621 442 to 7       436/442
(98 %)
0 diff
(100 %id)
BF514155   .j 1197 to 1519 30 to 352     Submitted on the opposite strand 323/369
(87 %)
8 diff
(97.9 %id)
AK126178 thymus .j 1200 to 3656 1 to 2457   tiling clone, available from FLJ,   2457/2457
(100 %)
1 diff
(100.0 %id)
DB129045 thymus .j 1201 to 1753 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AA282748 germinal center B cell .j 1297 to 1631 1 to 343       343/392
(87 %)
17 diff
(95.7 %id)
DA008016   .j 1578 to 2123 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BG741359 skin .j 2069 to 2831 1 to 765       765/768
(99 %)
15 diff
(98.1 %id)
EC465216 Prostate .j 2152 to 2246 95 to 1       95/95
(100 %)
0 diff
(100 %id)
EC512280 Prostate .j 2152 to 2246 95 to 1       95/95
(100 %)
0 diff
(100 %id)
CN267187 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 2702 to 3171 471 to 3   tiling clone, Submitted on the opposite strand 469/471
(99 %)
0 diff
(100 %id)
AJ003412   .j 2957 to 3182 235 to 9       227/235
(96 %)
0 diff
(100 %id)
DB344454 thymus .j 3088 to 3656 569 to 1       569/569
(100 %)
0 diff
(100 %id)
DB516440 testis .j 3188 to 3654 1 to 467     Submitted on the opposite strand 467/467
(100 %)
1 diff
(99.8 %id)
CN256960 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 1 to 533 1 to 533 T2A tiling clone,   533/533
(100 %)
3 diff
(99.5 %id)
DB443090 testis .l 1 to 471 1 to 471 T34N A71G T80R P115T tiling clone,   471/477
(98 %)
6 diff
(98.8 %id)
DB068567 testis .m 1 to 524 2 to 526 L14P A15C P16S L17T R18Q ... tiling clone, to resequence, capped   525/525
(100 %)
1 diff
(99.9 %id)
DB339946 testis .m 1269 to 1797 529 to 1   tiling clone, to resequence,   529/530
(99 %)
0 diff
(100 %id)
AA827816 germinal center B cell .n 1 to 464 485 to 22 P44S E59G tiling clone, AAA   464/464
(100 %)
4 diff
(99.2 %id)
FN131912 breast carcinoma .n 89 to 180 1 to 93   tiling clone,   93/93
(100 %)
3 diff
(96.8 %id)
BM561560 blood, natural killer cells, cell line .o 1 to 929 1 to 929   tiling clone,   929/1003
(92 %)
7 diff
(99.4 %id)
CA436845 Bone, Subchondral Bone .o 545 to 1201 675 to 19 exact tiling clone, AAA   657/657
(100 %)
0 diff
(100 %id)
DW413227 Liver .o 602 to 910 12 to 321       310/321
(96 %)
10 diff
(96.9 %id)
DW435603 Liver .o 602 to 844 12 to 255       244/255
(95 %)
7 diff
(97.3 %id)
AI990636 pooled germ cell tumors .o 614 to 1201 600 to 13 exact AAA   588/588
(100 %)
3 diff
(99.5 %id)
AW236974 pooled germ cell tumors .o 618 to 1201 594 to 11 exact AAA   584/585
(99 %)
2 diff
(99.7 %id)
N52745 multiple sclerosis lesions .o 638 to 805 25 to 191   fully sequenced,   167/191
(87 %)
6 diff
(96.9 %id)
AW195603 pooled .o 653 to 1203 558 to 5 A60S A61C C62R L64S T65N ... tiling clone,   554/558
(99 %)
1 diff
(99.9 %id)
N49968 multiple sclerosis lesions .o 787 to 1201 421 to 1 C4V R8E fully sequenced,   421/421
(100 %)
18 diff
(95.8 %id)
CR995298 T-Lymphocytes .p-u 1 to 631 1 to 645 P33X P42X P44X A46X S48X ... tiling clone,   645/645
(100 %)
9 diff
(98.7 %id)
AA744858 germinal center B cell .q-u 1 to 479 473 to 1 Q9H R10G Q13H L14V A28R ... tiling clone,   473/473
(100 %)
12 diff
(97.5 %id)
BI049922 placenta_normal .r-u 1 to 215 1 to 219 F2M S3* tiling clone,   219/219
(100 %)
16 diff
(92.7 %id)
CA420433 Bone, Enchondroma cell line Gene CRELD2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BI601971 brain, hypothalamus Gene CRELD2, variant not shown         Suspected internal deletion, this clone was ignored    
BU538617 adenocarcinoma, cell line, breast Gene CRELD2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_45209714   Gene CRELD2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154061088   Gene CRELD2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI